Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
This study has been completed.
Study NCT00080054 Information provided by Pharmacyclics
First Received: March 22, 2004 Last Updated: April 2, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glioma
Glioblastoma
Astrocytoma
Oligodendroglioma
Brain Neoplasm
Additional conditions recognized in this trial
Brain Neoplasms
Neoplasms
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Nervous System Neoplasms
Neuroectodermal Tumors
Interventions listed in this trial
Motexafin Gadolinium Injection
Additional drug interventions recognized in this trial
Motexafin gadolinium
Temozolomide
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Dermatologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Pharmacyclics
Back to top of Main Content
